Purpose To compare the diagnostic performance and clinical utility of three MRI protocols for detecting clinically significant prostate cancer (csPCa) according to prebiopsy risk. Materials and Methods This retrospective study included 390 male patients who underwent prostate multiparametric MRI (mpMRI) between January...
A. Ponsiglione, L. Cereser, M. De Martino et al.· Radiology: Imaging Cancer· 0 citations
Despite extensive clinical investigation, immunotherapy has failed to demonstrate consistent clinical benefit in prostate cancer (PCa), largely due to the development of an immunologically cold tumor microenvironment that resists immunotherapeutic strategies. However, the mechanisms through which systemic signals...
T. Raia, Martina Pecoraro, Alessandro Matteocci et al.· Journal of Experimental &...· 0 citations
OBJECTIVES
To compare a commercially available artificial intelligence (AI) risk-classification system with PI-RADS for detecting clinically significant prostate cancer (csPCa) on prostate MRI.
MATERIALS AND METHODS
This retrospective multicentre, multivendor diagnostic accuracy study included men who underwent prost...
Karsten Guenzel, Maarten G. Poirot, Almar van Loon et al.· European Radiology· 0 citations
To compare the diagnostic performance of MRI using the PI-RR scoring system and PSMA-PET/CT in detecting prostate cancer (PCa) local recurrence after radical prostatectomy (RP), and to identify clinical and imaging variables independently associated with recurrence. This retrospective, multicenter study evaluated 119 p...
L. Laschena, Martina Pecoraro, E. Messina et al.· La radiologia medica· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.